PETV vs. NXGL, BTCY, TTOO, MBOT, PAVM, MHUA, SSKN, AKLI, NURO, and INBS
Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include NEXGEL (NXGL), Biotricity (BTCY), T2 Biosystems (TTOO), Microbot Medical (MBOT), PAVmed (PAVM), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Akili (AKLI), NeuroMetrix (NURO), and Intelligent Bio Solutions (INBS). These companies are all part of the "surgical & medical instruments" industry.
PetVivo (NASDAQ:PETV) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
NEXGEL has higher revenue and earnings than PetVivo. NEXGEL is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
NEXGEL has a net margin of -77.19% compared to PetVivo's net margin of -1,016.64%. NEXGEL's return on equity of -49.49% beat PetVivo's return on equity.
PetVivo has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.
24.6% of PetVivo shares are owned by institutional investors. Comparatively, 2.2% of NEXGEL shares are owned by institutional investors. 20.1% of PetVivo shares are owned by company insiders. Comparatively, 27.2% of NEXGEL shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, NEXGEL had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for NEXGEL and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.00 equaled NEXGEL'saverage media sentiment score.
NEXGEL received 1 more outperform votes than PetVivo when rated by MarketBeat users.
Summary
NEXGEL beats PetVivo on 9 of the 13 factors compared between the two stocks.
Get PetVivo News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
